Advisor Partners LLC Astrazeneca PLC Transaction History

Advisor Partners LLC

$1.42 Billion
Q2 2022

A detailed history of Advisor Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Advisor Partners LLC holds 40,588 shares of AZN stock, worth $2.69 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

40,588

Previous 38,468 5.51%

Holding current value

$2.69 Million

Previous $2.55 Million 5.09%

% of portfolio

0.19%

Previous 0.16%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $125,631 - $150,816	2,120 Added 5.51%	40,588 $2.68 Million
Q1 2022 Apr 27, 2022	BUY	$55.72 - $67.12 $1,671 - $2,013	30 Added 0.08%	38,468 $2.55 Million
Q4 2021 Feb 04, 2022	SELL	$54.02 - $63.83 $130,728 - $154,468	-2,420 Reduced 5.92%	38,438 $2.24 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $512,763 - $561,030	9,229 Added 29.18%	40,858 $2.45 Million
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $10,216 - $12,697	211 Added 0.67%	31,629 $1.9 Million
Q1 2021 Jun 01, 2021	SELL	$47.16 - $54.44 $123,653 - $142,741	-2,622 Reduced 7.7%	31,418 $1.56 Million
Q4 2020 Feb 17, 2021	SELL	$48.52 - $58.02 $262,347 - $313,714	-5,407 Reduced 13.71%	34,040 $1.7 Million
Q3 2020 Nov 19, 2020	BUY	$53.07 - $61.1 $112,986 - $130,081	2,129 Added 5.71%	39,447 $2.16 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $324,155 - $415,986	7,521 Added 25.24%	37,318 $1.97 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $185,851 - $252,440	4,918 Added 19.77%	29,797 $1.33 Million
Q4 2019 Jan 24, 2020	BUY	$42.46 - $50.46 $37,025 - $44,001	872 Added 3.63%	24,879 $1.26 Million
Q3 2019 Oct 16, 2019	BUY	$40.12 - $45.47 $140,941 - $159,736	3,513 Added 17.14%	24,007 $1.07 Million
Q2 2019 Jul 26, 2019	BUY	$37.28 - $41.68 $17,596 - $19,672	472 Added 2.36%	20,494 $846,000
Q1 2019 Apr 23, 2019	SELL	$35.49 - $43.02 $2,803 - $3,398	-79 Reduced 0.39%	20,022 $809,000
Q4 2018 Jan 29, 2019	BUY	$36.86 - $41.49 $140,694 - $158,367	3,817 Added 23.44%	20,101 $763,000
Q3 2018 Nov 06, 2018	BUY	$34.76 - $39.72 $104,071 - $118,921	2,994 Added 22.53%	16,284 $644,000
Q2 2018 Jul 25, 2018	BUY	$34.55 - $37.05 $126,971 - $136,158	3,675 Added 38.22%	13,290 $467,000
Q1 2018 May 03, 2018	BUY	$32.97 - $36.63 $111,405 - $123,772	3,379 Added 54.19%	9,615 $336,000
Q4 2017 Jan 26, 2018	BUY	$32.09 - $34.78 $200,113 - $216,888	6,236	6,236 $221,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.

Account

Advisor Partners LLC Astrazeneca PLC Transaction History